Cosmos Health Inc. (NASDAQ:COSM) Short Interest Down 39.7% in January

Cosmos Health Inc. (NASDAQ:COSM) was the recipient of a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 531,900 shares, a drop of 39.7% from the January 15th total of 881,600 shares. Based on an average trading volume of 458,400 shares, the days-to-cover ratio is presently 1.2 days. Currently, 2.9% of the company’s stock are sold short.

Cosmos Health Stock Down 3.2 %

COSM opened at $0.62 on Friday. Cosmos Health has a fifty-two week low of $0.47 and a fifty-two week high of $1.58. The business has a 50-day moving average of $0.71 and a 200-day moving average of $0.84. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.44 and a quick ratio of 1.24. The company has a market capitalization of $14.40 million, a PE ratio of -0.25 and a beta of 5.56.

Insiders Place Their Bets

In other Cosmos Health news, CFO Georgios Terzis acquired 85,778 shares of the firm’s stock in a transaction on Friday, December 20th. The stock was purchased at an average cost of $0.58 per share, for a total transaction of $49,751.24. Following the transaction, the chief financial officer now owns 727,263 shares of the company’s stock, valued at $421,812.54. The trade was a 13.37 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Grigorios Siokas acquired 29,158 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were acquired at an average price of $0.86 per share, with a total value of $25,075.88. Following the completion of the transaction, the chief executive officer now directly owns 4,164,789 shares in the company, valued at approximately $3,581,718.54. This trade represents a 0.71 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 688,750 shares of company stock worth $437,803. 15.61% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Cosmos Health

An institutional investor recently raised its position in Cosmos Health stock. Geode Capital Management LLC raised its position in shares of Cosmos Health Inc. (NASDAQ:COSM) by 29.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 193,432 shares of the company’s stock after purchasing an additional 43,704 shares during the period. Geode Capital Management LLC owned 0.83% of Cosmos Health worth $129,000 as of its most recent SEC filing. 12.61% of the stock is currently owned by institutional investors.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.